Gray Wealth Management Inc. Sells 35 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Gray Wealth Management Inc. lessened its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 4.6% in the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 733 shares of the healthcare conglomerate’s stock after selling 35 shares during the quarter. Gray Wealth Management Inc.’s holdings in UnitedHealth Group were worth $386,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of UNH. Wellington Management Group LLP raised its stake in UnitedHealth Group by 2.1% in the 3rd quarter. Wellington Management Group LLP now owns 25,220,234 shares of the healthcare conglomerate’s stock worth $12,715,790,000 after purchasing an additional 527,526 shares in the last quarter. Morgan Stanley raised its position in shares of UnitedHealth Group by 13.8% in the fourth quarter. Morgan Stanley now owns 15,635,038 shares of the healthcare conglomerate’s stock valued at $8,289,386,000 after buying an additional 1,893,192 shares in the last quarter. Moneta Group Investment Advisors LLC raised its holdings in UnitedHealth Group by 100,076.4% in the 4th quarter. Moneta Group Investment Advisors LLC now owns 11,823,820 shares of the healthcare conglomerate’s stock valued at $6,268,753,000 after acquiring an additional 11,812,017 shares in the last quarter. Alliancebernstein L.P. lifted its position in shares of UnitedHealth Group by 3.5% during the 2nd quarter. Alliancebernstein L.P. now owns 11,749,819 shares of the healthcare conglomerate’s stock valued at $5,647,433,000 after acquiring an additional 399,739 shares during the period. Finally, Norges Bank bought a new position in shares of UnitedHealth Group in the fourth quarter worth $5,210,004,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, CAO Thomas E. Roos sold 858 shares of the stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now directly owns 32,289 shares in the company, valued at approximately $16,977,233.31. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. Insiders own 0.35% of the company’s stock.

UnitedHealth Group Trading Up 3.0 %

Shares of UnitedHealth Group stock traded up $14.19 during midday trading on Thursday, reaching $493.18. The company had a trading volume of 8,871,197 shares, compared to its average volume of 4,525,480. The firm has a market cap of $454.68 billion, a PE ratio of 30.38, a P/E/G ratio of 1.28 and a beta of 0.54. The stock has a fifty day moving average price of $489.51 and a 200 day moving average price of $515.38. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $554.70.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping the consensus estimate of $6.63 by $0.28. The company had revenue of $99.80 billion during the quarter, compared to analysts’ expectations of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. UnitedHealth Group’s revenue for the quarter was up 8.6% compared to the same quarter last year. During the same period in the prior year, the company posted $6.26 earnings per share. On average, equities analysts anticipate that UnitedHealth Group Incorporated will post 27.75 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were paid a $1.88 dividend. This represents a $7.52 annualized dividend and a yield of 1.52%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 45.97%.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on the stock. HSBC raised shares of UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 target price on the stock in a report on Thursday, April 4th. Oppenheimer restated an “outperform” rating and set a $610.00 target price on shares of UnitedHealth Group in a research note on Wednesday, January 17th. Wells Fargo & Company lowered their price target on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a report on Monday, April 8th. Bank of America reissued a “buy” rating and issued a $675.00 target price on shares of UnitedHealth Group in a report on Thursday, March 7th. Finally, Truist Financial reiterated a “buy” rating and set a $600.00 price objective on shares of UnitedHealth Group in a research report on Wednesday. Three equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $569.68.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.